Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hologic, Inc. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary hypothesis to be tested is:
The detection of breast cancer will be increased with tomosynthesis (3D) imaging
The purpose of this study is to determine if: 1 the detection of breast cancer will be increased with conventional (2D) imaging plus tomosynthesis (3D) imaging, or 2. if the the detection of breast cancer will be increased with tomosynthesis (3D) imaging alone.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Conventional + Tomosynthesis | Active Comparator | conventional (2D) imaging plus tomosynthesis (3D) imaging first then tomosynthesis alone 1 month later. |
|
| Tomosynthesis alone | Active Comparator | tomosynthesis (3D) imaging alone first then conventional (2D) imaging plus tomosyntheis 1 month later. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Tomosynthesis | Device | The mean glandular radiation dose for each image will be approximately 145 millirads (mrad) for a standard size breast (4.2 cm compressed breast thickness). |
| Measure | Description | Time Frame |
|---|---|---|
| Detection of Breast Cancer (Sensitivity) | Sensitivity is the number of true positives (TP) divided by the sum of TP and false negatives (FN): Sensitivity = TP / (TP+FN) | up to two years follow up for development of breast cancer |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Potential subjects with any of the following will not be enrolled in the study:
Any contraindications to mammographic screening, including, but not limited to:
Significant existing breast trauma
Under the age of 30 at the time of consent
Breast Implants
Prior Surgeries
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Elizabeth A Rafferty, MD | Massachusetts General Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| MGH | Boston | Massachusetts | 02114 | United States |
496 enrolled and 426 completed study, but no information available to distinguish study arms:
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | All Study Participants | All participants enrolled in study |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
496 participants enrolled overall, but no information available to distinguish study arms:
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | All Study Participants | All study participants in both arms. 496 enrolled and 426 completed study, but no information available to distinguish study arms. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Detection of Breast Cancer (Sensitivity) | Sensitivity is the number of true positives (TP) divided by the sum of TP and false negatives (FN): Sensitivity = TP / (TP+FN) | PI left institution in 2012; Data remaining did not include outcome measure and adverse event data. Institution contacted PI on numerous occasions. PI also does not have data. | Posted | up to two years follow up for development of breast cancer |
|
Not provided
PI left institution in 2012; Data remaining did not include outcome measure and adverse event data. Institution contacted PI on numerous occasions. PI also does not have data.
496 participants enrolled overall, but no information available to distinguish study arms:
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | All Study Participants | All participants enrolled in the study |
Not provided
Not provided
PI left institution in 2012; Data remaining did not include outcome measure and adverse event data. Institution contacted PI on numerous occasions. PI also does not have data.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Thomas J. Brady, MD | Massachusetts General Hospital | 6177268294 | tbrady@mgh.harvard.edu |
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D008327 | Mammography |
| ID | Term |
|---|---|
| D011859 | Radiography |
| D003952 | Diagnostic Imaging |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Conventional | Device | conventional (2D) imaging (standard mammography) |
|
| Participants |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
Tomosynthesis: The mean glandular radiation dose for each image will be approximately 145 millirads (mrad) for a standard size breast (4.2 cm compressed breast thickness). Conventional: conventional (2D) imaging (standard mammography) |
|
| 0 |
| 0 |
| 0 |
| 0 |
Not provided
Not provided
Not provided
| D017437 |
| Skin and Connective Tissue Diseases |